Metropolitan Life Insurance Company (MetLife)’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,579
| Closed | -$17.6K | – | 109 |
|
|
2024
Q1 | $17.6K | Hold |
1,579
| – | – | ﹤0.01% | 1926 |
|
|
2023
Q4 | $23.5K | Buy |
+1,579
| New | +$23.5K | ﹤0.01% | 1846 |
|
|
2023
Q3 | – | Sell |
-1,201
| Closed | -$9.02K | – | 2402 |
|
|
2023
Q2 | $9.02K | Buy |
+1,201
| New | +$9.02K | ﹤0.01% | 2346 |
|
|
2023
Q1 | – | Sell |
-1,308
| Closed | -$14.7K | – | 2314 |
|
|
2022
Q4 | $14.7K | Hold |
1,308
| – | – | ﹤0.01% | 2136 |
|
|
2022
Q3 | $12.5K | Buy |
+1,308
| New | +$12.5K | ﹤0.01% | 2234 |
|
|
2022
Q2 | – | Sell |
-1,242
| Closed | -$21K | – | 2371 |
|
|
2022
Q1 | $21K | Sell |
1,242
-3,965
| -76% | -$67K | ﹤0.01% | 2071 |
|
|
2021
Q4 | $112K | Hold |
5,207
| – | – | ﹤0.01% | 2412 |
|
|
2021
Q3 | $385K | Buy |
+5,207
| New | +$385K | 0.01% | 1621 |
|
|
2021
Q2 | – | Sell |
-4,954
| Closed | -$365K | – | 2716 |
|
|
2021
Q1 | $365K | Buy |
4,954
+1,953
| +65% | +$144K | 0.01% | 1611 |
|
|
2020
Q4 | $259K | Hold |
3,001
| – | – | ﹤0.01% | 1765 |
|
|
2020
Q3 | $113K | Buy |
+3,001
| New | +$113K | ﹤0.01% | 2147 |
|